🔎 Trials Near Me

Home › Autoimmune Diseases › Michigan › Ann Arbor

Autoimmune Diseases clinical trials in Ann Arbor, MI

6 studies for Autoimmune Diseases are looking for participants at sites in and around Ann Arbor (within about 30 miles). Open a study to see who can join and how to contact the study team.

Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →

RESET-Myositis: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Idiopathic Inflammatory Myopathy or Juvenile Idiopathic Inflammatory Myopathy

RecruitingPhase 2/3
  • University of Michigan - Accepting Young Adult and Juvenile Patients, Ann Arbor
Ages 6 to 75 · All sexes · Updated Nov 13, 2026 · NCT06154252

Screening Protocol for Genetic Diseases of Lymphocyte Homeostasis and Programmed Cell Death

RecruitingObservational study
  • University of Michigan, Ann Arbor
1 Month – 100 Years · All sexes · Updated Nov 12, 2026 · NCT00246857

Daratumumab in Primary Antiphospholipid Syndrome

RecruitingPhase 1/2
  • University of Michigan, Ann Arbor
Ages 18 to 65 · All sexes · Updated Oct 21, 2026 · NCT05671757

RESET-SSc: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201, a CD19-CAR T Cell Therapy, in Subjects With Systemic Sclerosis

RecruitingPhase 2/3
  • University of Michigan, Ann Arbor
Ages 18 to 75 · All sexes · Updated Oct 16, 2026 · NCT06328777

A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)

RecruitingObservational study
  • University of Michigan, Ann Arbor
All ages · All sexes · Updated Jul 6, 2026 · NCT01351545

About Autoimmune Diseases

Autoimmune diseases are where your immune system attacks healthy cells in your body by mistake. Learn about the symptoms, tests, and treatments.

More about Autoimmune Diseases on MedlinePlus

Autoimmune Diseases trials in other cities

Other studies in Ann Arbor

From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.